Cargando…
LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters
The SARS-CoV-2 pandemic demonstrated the need for potent and broad-spectrum vaccines. This study reports the development and testing of a lumpy skin disease virus (LSDV)-vectored vaccine against SARS-CoV-2, utilizing stabilized spike and conserved nucleocapsid proteins as antigens to develop robust...
Autores principales: | de Moor, Warren R. J., Williamson, Anna-Lise, Schäfer, Georgia, Douglass, Nicola, Gers, Sophette, Sutherland, Andrew D., Blumenthal, Melissa J., Margolin, Emmanuel, Shaw, Megan L., Preiser, Wolfgang, Chapman, Rosamund |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383203/ https://www.ncbi.nlm.nih.gov/pubmed/37515096 http://dx.doi.org/10.3390/v15071409 |
Ejemplares similares
-
Influence of the Viral Superoxide Dismutase (SOD) Homologue on Lumpy Skin Disease Virus (LSDV) Growth, Histopathology and Pathogenicity
por: Douglass, Nicola, et al.
Publicado: (2020) -
A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters
por: Margolin, Emmanuel, et al.
Publicado: (2023) -
Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
por: Chapman, Ros, et al.
Publicado: (2021) -
Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector
por: van Diepen, Michiel, et al.
Publicado: (2021) -
A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV)
por: Shen, Yen-Ju, et al.
Publicado: (2011)